Statins are proven to lower risk of heart attacks, strokes, and cardiovascular mortality in people with high Lp(a).
Lp(a) makes clots form more easily and resist breakdown via OxPL and apo(a)
Louis shares a summary of an ATVB commentary by Rafael Zubiran explaining why high Lp(a) may be worse than LDL. Its oxidized phospholipids activate monocytes to make tissue factor, and apo(a) resembles plasminogen and competes with clot breakdown, producing denser, harder-to-dissolve clots. Louis notes statins, especially atorvastatin, may neutralize OxPL and aspirin lowers clotting risk.
